{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:57Z","timestamp":1794047397308,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2021.279895","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T04:12:33Z","timestamp":1635999153000},"page":"555-557","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study"],"prefix":"10.3324","volume":"107","author":[{"given":"Nicola","family":"Sgherza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Curci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelantonio","family":"Vitucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella Vita Russo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"33562","doi-asserted-by":"crossref","unstructured":"Chari A, Samur MK, Martinez-Lopez J. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood. 2020; 136(26):3033-3040.","DOI":"10.1182\/blood.2020008150"},{"key":"33563","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-L\u00f3pez J, Mateos MV, Encinas C. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood Cancer J. 2020; 10(10):103.","DOI":"10.1038\/s41408-020-00372-5"},{"key":"33564","doi-asserted-by":"crossref","unstructured":"Engelhardt M, Shoumariyeh K, R\u00f6sner A. Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany. Haematologica. 2020; 105(12):2872-2878.","DOI":"10.3324\/haematol.2020.262758"},{"key":"33565","doi-asserted-by":"crossref","unstructured":"Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M. A case series of monoclonal gammopathy of undetermined significance and COVID-19. Br J Haematol. 2020; 190(3):e130-e133.","DOI":"10.1111\/bjh.16906"},{"key":"33566","doi-asserted-by":"crossref","unstructured":"Kyle RA, Larson DR, Therneau TM. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018; 378(3):241-249.","DOI":"10.1056\/NEJMoa1709974"},{"key":"33567","doi-asserted-by":"crossref","unstructured":"van de Donk NW, Palumbo A, Johnsen HE. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica. 2014; 99(6):984-996.","DOI":"10.3324\/haematol.2013.100552"},{"key":"33568","doi-asserted-by":"crossref","unstructured":"Kristinsson SY, Bj\u00f6rkholm M, Andersson TM. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica. 2009; 94(12):1714-1720.","DOI":"10.3324\/haematol.2009.010066"},{"key":"33569","doi-asserted-by":"crossref","unstructured":"Kristinsson SY, Tang M, Pfeiffer RM. Monoclonal gammopathy of undetermined significance and risk of infections: a populationbased study. Haematologica. 2012; 97(6):854-858.","DOI":"10.3324\/haematol.2011.054015"},{"key":"33570","doi-asserted-by":"crossref","unstructured":"Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775-1776.","DOI":"10.1001\/jama.2020.4683"},{"key":"33571","doi-asserted-by":"crossref","unstructured":"Lee H, Tay J, Street L, Duggan P, Jim\u00e9nez-Zepeda VH. Monoclonal gammopathy of undetermined significance clinic during the coronavirus disease-19 pandemic: caring for the vulnerable in an academic medical center. Rev Invest Clin. 2021; 73(4):259-264.","DOI":"10.24875\/RIC.21000078"},{"key":"33572","doi-asserted-by":"crossref","unstructured":"Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I. The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of antimyeloma treatment. Blood Cancer J. 2021; 11(8):138.","DOI":"10.1038\/s41408-021-00530-3"},{"key":"33573","unstructured":"Publisher Full Text|"},{"key":"33574","doi-asserted-by":"crossref","unstructured":"Ludwig H, Meckl A, Engelhardt M. Compliance with vaccination recommendations among patients with multiple myeloma: a real world experience. Hemasphere. 2021; 5(7):e597.","DOI":"10.1097\/HS9.0000000000000597"},{"key":"33575","doi-asserted-by":"crossref","unstructured":"Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Terpos E, Dimopoulos MA. SARS-CoV-2 vaccines in patients with multiple myeloma. Hemasphere. 2021; 5(3):e547.","DOI":"10.1097\/HS9.0000000000000547"},{"key":"33576","doi-asserted-by":"crossref","unstructured":"Quinn SJ, Anderson LA, Lohfeld L, McShane CM. The psychosocial impact of the COVID-19 pandemic on patients with monoclonal gammopathy of undermined significance, smouldering and active myeloma: findings from an international survey. Br J Haematol. 2021; 194(2):294-297.","DOI":"10.1111\/bjh.17427"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279895\/73847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279895\/74111","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10445\/73847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:36Z","timestamp":1794045636000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.279895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.279895","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}